1. Home
  2. UNM vs RDY Comparison

UNM vs RDY Comparison

Compare UNM & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unum Group

UNM

Unum Group

N/A

Current Price

$86.23

Market Cap

12.0B

Sector

Finance

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$11.80

Market Cap

11.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNM
RDY
Founded
1848
1984
Country
United States
India
Employees
10910
N/A
Industry
Accident &Health Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
11.8B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
UNM
RDY
Price
$86.23
$11.80
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$83.36
$16.90
AVG Volume (30 Days)
1.3M
3.0M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
2.26%
0.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.72
Revenue Next Year
$4.98
$3.50
P/E Ratio
$17.16
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$68.28
$11.36
52 Week High
$93.22
$15.67

Technical Indicators

Market Signals
Indicator
UNM
RDY
Relative Strength Index (RSI) 45.15 31.01
Support Level $85.51 N/A
Resistance Level $92.79 $13.96
Average True Range (ATR) 1.59 0.38
MACD -0.45 -0.19
Stochastic Oscillator 41.90 13.52

Price Performance

Historical Comparison
UNM
RDY

About UNM Unum Group

Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The Unum USA segment generates the majority of revenue. The firm markets its products through brokers.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: